| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |